Lori Pierce: Therapies are of no use when patients can’t get off work to be treated

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As she became president of the American Society of Clinical Oncology, Lori J. Pierce decided to focus on equity in cancer care as her year-long presidential theme.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert A. Winn, MD
Director, VCU Massey Cancer Center; Senior associate dean for cancer innovation, VCU School of Medicine; Professor, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University
Table of Contents

YOU MAY BE INTERESTED IN

FDA has been taking a look at psychedelics as a potential treatment for psychiatric and substance abuse disorders, recently publishing a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA. 
In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
Robert A. Winn, MD
Director, VCU Massey Cancer Center; Senior associate dean for cancer innovation, VCU School of Medicine; Professor, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login